ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Down 10.2% – What’s Next?

ChronoScale Corporation Common Stock (NASDAQ:CHRN)’s stock price was down 10.2% during trading on Tuesday. The company traded as low as $10.38 and last traded at $10.44. Approximately 91,399 shares traded hands during trading, a decline of 59% from the average daily volume of 221,147 shares. The stock had previously closed at $11.62.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Weiss Ratings lowered ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a report on Friday, October 23rd. Compass Point initiated coverage on ChronoScale Corporation Common Stock in a research report on Friday, October 16th. They set a “buy” rating and a $25.00 target price on the stock. Finally, Northland Securities initiated coverage on shares of ChronoScale Corporation Common Stock in a report on Friday, September 18th. They set an “outperform” rating and a $32.00 price objective on the stock. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, ChronoScale Corporation Common Stock presently has a consensus rating of “Hold” and an average target price of $21.00.

ChronoScale Corporation Common Stock Trading Down 7.1%

The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.30 and a current ratio of 0.30. The company has a market cap of $1.56 billion, a price-to-earnings ratio of -2.48 and a beta of 1.12. The company’s fifty day moving average is $17.20 and its two-hundred day moving average is $16.10.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its quarterly earnings data on Wednesday, October 14th. The company reported ($0.29) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. The business had revenue of $41.48 million during the quarter. On average, research analysts anticipate that ChronoScale Corporation Common Stock will post -0.49 EPS for the current year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.